e r t i Hemodynamic abnormalities are important in the pathogenesis of the excess mesangial matrix deposition of diabetic and other glomerulopathies. p38-Mitogen-activated protein (MAP) kinase, an important intracellular signaling molecule, is activated in the glomeruli of diabetic rats. We studied, in human mesangial cells, the effect of stretch on p38 MAP kinase activation and the role of p38 MAP kinase in stretchinduced fibronectin and transforming growth factor-1 ( T G F-1) accumulation. p38 MAP kinase was activated by stretch in a rapid (11-fold increase at 30 min, P < 0.001) and sustained manner (3-fold increase at 33 h, P < 0.001); this activation was mediated by protein kinase C (PKC). Stretch-induced fibronectin and T G F-1 protein levels were completely abolished (100% inhibition, P < 0.001; and 92% inhibition, P < 0.01, respectively) by SB203580, a specific p38 MAP kinase inhibitor. At 33 h, TGF-1 blockade did not a ffect stretch-induced fibronectin production, but partially prevented stretch-induced p38 MAP kinase activation (59% inhibition, P < 0.05). TGF-1 induced fibronectin accumulation after 72 h of exposure via a p38 MAP kinase-dependent mechanism (30% increase over control, P < 0.01). In human mesangial cells, stretch activates, via a PKC-dependent mechanism, p38 MAP kinase, which independently induces TGF-1 and fibronectin. In turn, TGF-1 contributes to maintaining late p38 MAP kinase activation, which perpetuates fibronectin accumulation. D i a b e t e s 4 9 :6 5 5-661, 2000
A lteration in intraglomerular hemodynamics is a common feature of several forms of renal disease, including diabetic nephropathy, and the mesangium is a primary target of injury in these conditions (1,2). Treatments that lower glomerular capillary pressure have a potent renoprotective effect (3-5).
Mesangial cells, via their cellular projections, are directly connected with the glomerular capillary basement membrane and are thus affected by the mechanical insult of an increased glomerular capillary pressure. The application of mechanical stretch to rat mesangial cells results in an increased production of extracellular matrix and transforming growth factor-1 ( T G F-1), a potent prosclerotic cytokine (6,7).
p38 Mitogen-activated protein (MAP) kinase, a member of the MAP kinase family, is activated in response to various extracellular stresses, such as hyperosmolar and oxidative stress, and by several cytokines (8-10), including T G F-1 (11). p38 MAP kinase is activated in the glomeruli of diabetic rats (10) and induces in various cell types transcription factors (12-14), which can enhance extracellular matrix gene expression (15-18). MAP kinases are induced by stretch in rat mesangial cells (19) , and Erk1 and Erk2 have been implicated in matrix production (20), but there is no information to date on the role of p38 MAP kinase in stretch-induced TGF-1 and matrix production in human mesangial cells.
The present study was designed to test in human mesangial cells whether p38 MAP kinase is implicated in stretchinduced fibronectin and TGF-1 production and to examine the interaction between p38 MAP kinase and TGF-1 in relation to extracellular matrix production.
Cell culture. Human mesangial cells were isolated as previously described (21). B r i e fly, normal renal cortex was taken from the opposite tumor-free pole of nephrectomy specimens. Nephrectomy was performed for localized, capsulated grade 1 hypernephromas. Tissue was analyzed by light microscopy and immunofluorescence to exclude the presence of tumor cells and glomerular abnormalities (22). Intact glomeruli were collected by serial sieving of cortical homogenates. Cells obtained from three separate kidneys were used in this study. After digestion with collagenase (type IV, 750 U/ml), the isolated glomeruli were seeded in culture flasks. After the outgrowth of mesangial cells, the glomeruli were removed by washing with phosphate-buffered saline (PBS) and the cells were cultured in RPMI 1640 medium, supplemented with insulin-transferrin-selenium and L-glutamine and containing 20% FCS, 7 mmol/l glucose, 100 IU/ml penicillin, and 1 0 0 mg/ml streptomycin in a humidified 5% CO 2 incubator at 37°C. Mesangial cells were harvested using 0.25% trypsin and 0.5% EDTA. The cells were stellate or fusiform in appearance, grew in multilayers, formed hillocks in long-term culture, and stained for -smooth muscle actin by direct immunofluorescence. Cells did not stain for cytokeratin, factor VIII, common leukocyte antigen (Dako, High Wycombe, U.K.), and Thy-1 (Serotec, Oxford, U.K.), respectively excluding contamination of epithelial cells, endothelial cells, lymphomonocytes, and human fibroblasts (23). Studies were performed between passages 4 and 7, while the cells retain their peculiar morphologic and immunofluorescent phenotypic features. Application of mechanical stretch to cultured cells. Mesangial cells were seeded in equal numbers (12,000/cm 2 ) into six-well type I collagen-coated silicon e l a s t o m e r-base culture plates (Flex I plates) and control plates (Flex II plates). After 3-5 days, they were serum deprived and incubated in insulin-free medium for 48 h, and then subjected to repeated stretch/relaxation cycles by mechanical deformation using a stress unit. The stress unit is a modification of the unit initially described by Banes et al. (24) and consists of a vacuum unit and a baseplate. A vacuum was cyclically applied (60 cycles/min) to the rubber-base plates via the baseplate, which was placed in a humidified incubator with 5% CO 2 at 37°C. Cells were exposed to an average 10% uniaxial elongation, which mimics that present in vivo in glomeruli exposed to supernormal pressure levels and is known in vitro to induce mesangial cell cytokines and matrix production (6,7,25). In preliminary experiments, we found that an average cell elongation of 4%, believed to correspond to the physiological stretch induced by a normal intracapillary pressure (26), had no effect on p38 MAP kinase activity or TGF-1 and fibronectin production (data not shown). Stretch and control experiments were carried out simultaneously with cells derived from a single pool. Control cells were grown in nondeformable but otherwise identical plates (Flex II plates) in parallel. Mesangial cell exposure to hyperosmolar stress. Serum-and insulindeprived human mesangial cells were exposed for 20 min to either iso-osmolar (290 mosm/l) or hyperosmolar (440 mosml/l) media. Hyperosmolar medium was obtained by supplementation with 150 mmol/l NaCl. Osmolarity was confir m e d by a cryoscopic osmometer (Osmomat 30; Gonotec, Berlin). Cell number determination. Cells were harvested with 0.25% trypsin and 0.5% E D TA and the cell number determined by a Coulter Cell Counter (Coulter Electronics, Luton Beds, U.K.). Fibronectin and TGF-1 protein measurement. Culture supernatants from all experimental conditions were collected, centrifuged to remove cell debris, and stored at -70°C for analysis. For each experiment, both fibronectin and TGF-1 protein levels were determined within a single-assay run. After activation of latent TGF-1 by acidification, total TGF-1 protein concentration was measured by ELISA (range 16-1,000 pg/ml; intra-assay coefficient of variation [CV], 1.6%) using a mouse monoclonal and a rabbit polyclonal anti-human TGF-1 . Fibronectin protein levels were measured with a modification of the competitive inhibition ELISA described by Rennard et al. (27) (range 0.05-0.5 µg/ml; intra-assay C V, 5%). Briefly, 96-well cluster plates were coated overnight at 4°C with 1 0 0 ng/well of human fibronectin. Samples were incubated overnight at 4 o C with rabbit-anti-human fibronectin as primary antibody. After washing, samples and standards were added to the plates and incubated for 1 h at 37°C. Immunocomplexes were detected by horseradish peroxidase (HRP)-conjugated goat-anti-rabbit IgG and revealed by 3,3 , 5 , 5 -tetramethylbenzidine dihydrochloride substrate. The reaction was stopped with H 2 S O 4 , and the absorbance measured at 450 n m . Measurements of pericellular polymeric fib r o n e c t i n . Levels of pericellular polymeric fibronectin were determined in deoxycolate-insoluble and SDS-soluble protein extracts as previously described (28). Cells were lysed in 2% deoxycolate, 0.02 mol/l Tris-HCl (pH 8.8), 2 mmol/l phenylmethylsulfonyl flu o r i d e (PMSF), 2 mmol/l EDTA, 2 mmol/l iodoacetic acid, and 2 mmol/l N-ethylmaleimide. The cell lysates were centrifuged at 10,000 rpm for 20 min to spin out deoxycolate-insoluble material, which was then dissolved in 1% SDS, 0.02 mol/l Tris-HCl (pH 8.8), 2 mmol/l PMSF, 2 mmol/l EDTA, 2 mmol/l iodoacetic acid, and 2 mmol/l N-ethyl-maleimide. Deoxycolate-insoluble and SDS-soluble extracts were separated by 5% SDS-PAGE and electrotransferred to nitrocellulose membranes. The membranes were blocked in 5% skimmed milk in Tris bufferTw e e n-20 (pH 7.6), then incubated with a rabbit anti-fibronectin antibody. Membranes were then washed in Tris buffer-Tween-20 and incubated with HRP-linked secondary antibodies. Detection was performed by enhanced chemiluminescence and the band intensity quantitated by laser densitometry. Measurement of active p38 MAP kinase levels and p38 MAP kinase a c t i v i t y. Cells were harvested in a Tris-HCl (50 mmol/l, pH 7.6) lysis buffer containing 0.01 mmol/l sodium pyrophosphate, 100 mmol/l NaF, 20 mmol/l EDTA , 2 0 mmol/l EGTA, 1 mmol/l Na 3 V O 4 , 1 mmol/l PMSF, 1 mg/ml leupeptin, 1 m g / m l aprotinin, and 1% Triton X-100. To determine total and phospho-p38 MAP kinase levels, total protein extracts were separated by 10% SDS-PAGE and electrotransferred to nitrocellulose membranes. The membranes were blocked in 5% skimmed milk in Tris buffer-Tween-20 (pH 7.6), then incubated with either a goat anti-p38-MAP kinase antibody, detecting total p38 MAP kinase, or with a rabbit anti-phospho-p38-MAP kinase antibody, binding only to the active form of p38 MAP kinase. Membranes were then washed in Tris buffer-Tween-20 and incubated with HRP-linked secondary antibodies. Detection was performed by enhanced chemiluminescence and the band intensity quantitated by laser densitometry. To determine p38 MAP kinase activity, total p38 MAP kinase was immunoprecipitated from total cell lysates using a rabbit anti-p38 MAP antibody and protein A sepharose beads. Immunoprecipitates were then incubated with ATF-2 fusion protein (2 µg) in the presence of ATP (200 µg) and kinase buffer for 30 min at 30°C. Phosphorylation of ATF-2 at Thr71 (14) was determined by Western blotting using a specific rabbit anti-phospho-ATF-2 (Thr71) antibody as described above. Inhibition of protein kinase C and p38 MAP kinase. In the experiments to inhibit protein kinase C (PKC) activity, serum-and insulin-deprived human mesangial cells were exposed to cyclical stretch for 30 min in the presence or absence of calphostin C, a specific PKC inhibitor. Calphostin C was used at a 1-µmol/l concentration added to the culture media 4 h before the experiment.
In the experiments to inhibit p38 MAP kinase, cells were serum-and insulindeprived for 48 h and then exposed to stretch for various time periods up to 33 h, because preliminary experiments showed that longer periods of serum deprivation affected cell viability. p38 MAP kinase was inhibited by the addition of the imidazole derivative SB203580. This compound inhibits p38 MAP kinase activity by binding to the p38 MAP kinase ATP pocket (29), and it does not inhibit other relevant kinases such as extracellular signal-regulated kinase (ERK) and PKC (30-33). Because SB203580 has an inhibitory effect on the c-Jun NH 2 -terminal kinase (JNK)-2 isoforms at high concentrations (>10 µmol/l) (33), we used lower concentrations of 1, 5, and 10 µmol/l. Inhibition experiments on basal protein production were carried out simultaneously. Data presentation and statistical analysis. The number of experiments, carried out in triplicate, is reported in each figure legend. All data are presented as m e a n s ± SE. Student's t test was used for the comparison between two groups. When more than two groups were studied, data were analyzed by analysis of variance and, if significant, the Newman-Keuls procedure was used for post hoc comparisons. Values for P < 0.05 were considered signific a n t .
R E S U LT S
p38 MAP kinase is expressed by human mesangial cells and is activated in response to hyperosmolar stress. Hyperosmolar stress is an established p38 MAP kinase activator in various cell types (9). To determine whether p38 MAP kinase can be activated in human mesangial cells, we exposed human mesangial cells for 20 min to either isoosmolar (290 mosm/l) or hyperosmolar (440 mosm/l) media and analyzed total protein extracts by immunoblotting. Using a specific anti-p38 MAP kinase antibody, a single band ( ~ 4 0 kDa), consistent with the reported molecular weight of p38 MAP kinase (9), was detected, indicating that p38 MAP kinase is expressed as a single isoform in human mesangial cells. Activated phospho-p38 MAP kinase levels were very low in cells exposed to iso-osmolar media, but were induced by exposure to hyperosmolar media, which, however, had no effect on total p38 MAP kinase (Fig. 1 ) . Stretch induces p38 MAP kinase activation in human mesangial cells. To test the effect of mechanical stretch on p38 MAP kinase, serum-and insulin-deprived human mesangial cells were exposed to cyclical stretch (elongation 10%) for short (1, 5, 10, 30, and 60 min) and long (6, 12, and 33 h) time periods. We found that stretch induced p38 MAP kinase activation by 5 min, with a maximum 11-fold increase at 30 m i n . High levels were sustained for up to 33 h. Total p38 MAP kinase protein levels were unaltered by stretch. A stretchinduced increase in p38 MAP kinase activity peaking at 30 min was also observed in an in vitro kinase assay. The addition of SB203580 (1 µmol/l) resulted in a 94% reduction of stretchinduced p38 MAP kinase activity, indicating the inhibitory efficacy of this compound in our experimental setting (Fig. 2 ) .
Stretch-induced p38 MAP kinase activation is PKC dependent. To investigate the molecular mechanism of p38 MAP kinase activation by stretch, we examined whether the PKC pathway was involved. Mesangial cells were exposed to stretch for 30 min in the presence or absence of calphostin C (1 µmol/l). Stretch-induced p38 MAP kinase activation was completely abolished by calphostin C (n = 3, P < 0.05 s t r e t c h + calphostin vs. stretch) (Fig. 3) and was thus considered PKC dependent. Stretch-induced fibronectin in human mesangial cells is p38 MAP kinase dependent. The application of stretch to rat mesangial cells induces fibronectin and other matrix components (34) (Fig. 4A) . There was also a significant increase in pericellular polymeric fib r onectin (1.3 ± 0.03-fold increase over control, P < 0.05), indicating that the increase in fibronectin in the supernatant was paralleled by an enhanced fibronectin incorporation in the matrix. At the 33-h time point, SB203580 (1, 5, and 10 µmol/l) completely abolished at all concentrations the increase in fib r onectin levels in the supernatant seen in response to stretch, with no effect on basal fibronectin levels (Fig. 4B) . Stretch induces TGF-1 via p38 MAP kinase. Given the importance of TGF-1 in matrix production in renal disease, we tested the role of p38 MAP kinase in stretch-induced T G F-1. Mesangial cells were exposed to cyclical stretch for 6, 12, 24, and 33 h in the presence or absence of SB203580 ( 1 µmol/l). A rise in TGF-1 protein levels was seen after 2 4 h of stretch and reached a peak 1.5-fold increase by 33 h. The addition of SB203580 abolished stretch-induced TGF-1 protein levels at 33 h, but did not affect basal TGF-1 levels ( F i g . 4C), indicating that stretch-induced TGF-1 is p38 MAP kinase dependent.
Late p38 MAP kinase activation by stretch is TGF-1 d e p e n d e n t . T G F-1 is a known activator of p38 MAP kinase in other cell types (11).
Having established that stretch activates p38 MAP kinase, which induces TGF-1, we investigated the effect of TGF-1 on p38 MAP kinase in human mesangial cells. After preliminary dose-response experiments, mesangial cells were exposed to rhTGF-1 (1.1 ng/ml) for 1, 10, 15, and 30 min. TGF-1 induced a twofold increase in activated phospho-p38 MAP kinase levels by 1 min, which rose to a fourfold increase at 15 and 30 min (data not shown).
To test the role of TGF-1 in stretch-induced p38 MAP kinase activation, mesangial cells were exposed to cyclical stretch for 6, 12, and 33 h in the presence or absence of a spec i fic neutralizing anti-TGF-1 antibody (1 µg/ml). Stretchinduced p38 MAP kinase activation was not affected at the early time points of 6 and 12 h, but was significantly reduced, though not abolished, at 33 h by TGF-1 neutralization ( F i g . 5). This suggests that late stretch-induced p38 MAP kinase activation is, at least in part, TGF-1 dependent. T G F-1 requires p38 MAP kinase for the induction of fib r o n e c t i n . To test the role of TGF-1 in stretch-induced fibronectin, human mesangial cells were exposed to cyclical stretch for 33 h in the presence of a pan-neutralizing a n t i -T G F-antibody (20 µg/ml) or control nonimmune IgG. A pan-neutralizing anti-TGF-antibody previously used by others (35, 36) P < 0.01; stretch vs. stretch + anti-TGF-= NS; n = 4), confirming that at this 33 h time point, stretch-induced fib r onectin was TGF-independent. To further investigate this relationship, we performed time-course experiments to examine the effect of TGF-1 on fibronectin production. The addition of exogenous TGF-1 (1.1 ng/ml) to mesangial cells induced a significant 1.3-fold increase in fibronectin protein levels after 72 h with no increase at earlier time points (6, 12, 24, and 48 h). In the presence of the p38 MAP kinase inhibitor SB203580 (1 µmol/l), TGF-1-induced fibronectin production was completely abolished (Fig. 6) , indicating that this late T G F-1-induced fibronectin production was p38 MAP k i n a s e -d e p e n d e n t .
D I S C U S S I O N
This study demonstrates that stretch activates p38 MAP kinase in human mesangial cells and suggests that p38 MAP kinase activation has a central role in the process of extracellular matrix accumulation initiated by a mechanical insult. The application of cyclical stretch to human mesangial cells induced a significant 11-fold increase in activated p38 MAP kinase levels. This provides the first evidence of stretchinduced MAP kinase activation in any human cell.
The complete abrogation of p38 MAP kinase activation in the presence of the PKC inhibitor calphostin C strongly supports a role of PKC as an intracellular mediator of stretchinduced p38 MAP kinase activation. PKC is rapidly activated within minutes in stretched rat mesangial cells (37) and mediates glucose-induced p38 MAP kinase activation in vascular smooth muscle cells (38) .
p38 MAP kinase activation occurred within 5 min, reached a peak at 30 min, and was sustained for up to 33 h. This sustained p38 MAP kinase activation is of interest, because in rat mesangial cells, stretch-induced activation of other MAP kinases, such as Erk1 and Erk2, occurs within 10 min, returning to basal levels by 60 min (20). This late p38 MAP kinase activation is temporally related to an increase in TGF-1 protein levels and is reduced by TGF-1 inhibition, indicating that while the rapid stretch-induced p38 MAP kinase activation is T G F-1 independent, TGF-1 becomes important in the sustained activation of p38 MAP kinase. Accordingly, the addition of TGF-1 to human mesangial cells resulted in p38 MAP kinase activation, confirming findings previously reported in nonrenal cell types (11). The intracellular mediator(s) responsible for TGF-1-induced p38 MAP kinase activation remain(s) to be elucidated, but the TGF--activated kinase 1 , known to stimulate p38 MAP kinase activity, is a likely candidate (39) .
The magnitude of stretch-induced p38 MAP kinase activation was comparable to that observed in human mesangial cells exposed to hyperosmolar media. Furthermore, it was greater than that reported in cardiac and vascular smooth muscle cells exposed to angiotensin II, endothelin 1, and high glucose (39) (40) (41) .
A physiological degree of stretch (4% elongation) does not induce cytokine or matrix production in human mesangial cells (25,26), nor does it induce p38 MAP kinase activation in cardiac cells (42) or human mesangial cells. Thus, degrees of stretch-simulating pathological states (10% elongation) seem to be necessary for these effects.
Our data indicate that the stretch-induced increase in mesangial cell TGF-1 and fibronectin protein production is p38 MAP kinase dependent since it was abolished by SB203580, a specific p38 MAP kinase inhibitor. This inhibitor was highly effective in blocking p38 MAP kinase activity in response to stretch in our experimental setting. Although the highest dose of SB203580 used (10 µmol/l) may not be entirely selective for p38 MAP kinase because of its inhibitory effect on JNK-2 (33), an equal effect was seen at lower doses with no loss of efficacy. Moreover, stretch inducing a 10% elongation does not activate JNK in rat mesangial cells (19,20,44) . p38 MAP kinase phosphorylates transcription factors inducing c-f o s and c-jun transcription (12-14). c-f o s and c-j u n combine to form the AP1 transcription complex that binds to and activates genes with a 12-O-tetradecanoylphorbol 13-acetate (TPA)-response element (TRE) in their promoter region. TGF-1 and fibronectin both contain TRE regions (15,16) and p38 MAP kinase is thus likely to induce fib r o n e c t i n and TGF-1 production via this mechanism. The expression of c-fos has been shown to be induced by stretch in rat mesangial cells (6).
Under our experimental conditions, the effect of stretch and T G F-1 on fibronectin was more modest compared with that of other studies (7). Previous studies have used rat mesangial cells, which may have a different quantitative response. In addition, we specifically used serum-and insulin-free experimental conditions to test purely the effect of a mechanical insult. Serum induces a 50-60% augmentation in stretchinduced matrix production in mesangial cells (34, 38) and insulin enhances TGF-1 and fibronectin production (45), thus confounding and amplifying the effect of stretch.
The addition of TGF-1 to mesangial cells resulted in fib r onectin accumulation after 72 h via a p38 MAP kinase-dependent mechanism, suggesting that p38 MAP kinase may be an important pathway for a number of matrix-promoting stimuli. At 33 h, however, TGF-1 blockade did not affect stretchinduced fibronectin, in accord with the observation that stretch-induced (I) collagen expression precedes that of T G F-1 (34) and that in the rat remnant kidney model, early alterations in matrix accumulation precede any increase in local TGF-1 expression (46) . Furthermore, in immunohistochemistry studies using different degrees of cell-stretching in a single culture well, the magnitude of matrix production correlated directly with the degree of cell elongation (34, 47) , a finding against a role of a secreted cytokine, such as T G F-1, and in favor of a direct effect of stretch. Hirakata et al. (35) reported that stretch-induced fibronectin gene expression in rat mesangial cells was abolished by an a n t i -T G F-1 antibody, whereas Yasuda et al. (34) and Riser et al. (36) found no effect of TGF-1 inhibition on stretchinduced collagen production. Our data suggest that stretch induces fibronectin via a biphasic signaling pathway. Stretch, via PKC, causes early activation of p38 MAP kinase, which induces TGF-1 and fibronectin production. In turn, TGF-1 maintains late p38 MAP kinase activation, which perpetuates fibronectin production (Fig. 7 ) .
These findings could have important clinical pathophysiological implications for renal disease. p38 MAP kinase is important in mediating inflammatory responses in neutrophils and cell hypertrophy in the heart (8, 48) , and this is the first evidence that p38 MAP kinase participates in the intracellular signaling cascade leading to mesangial cell extracellular matrix production and, presumably, glomerulosclerosis. The interplay between p38 MAP kinase and TGF-1 , described here, provides a potential mechanism for a progressive and sustained sclerotic process, initially triggered by a hemodynamic insult. Our observations may have particular relevance for diabetes because p38 MAP kinase is also activated by high glucose via a PKC-dependent mechanism (38) , and active p38 MAP kinase levels are augmented in vivo in glomeruli from diabetic rats (10). 
